{"id":224143,"date":"2025-10-28T02:22:43","date_gmt":"2025-10-28T07:22:43","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2025\/10\/chemists-discover-antibiotic-for-drug-resistant-bacteria-hiding-in-plain-sight"},"modified":"2025-10-28T02:22:43","modified_gmt":"2025-10-28T07:22:43","slug":"chemists-discover-antibiotic-for-drug-resistant-bacteria-hiding-in-plain-sight","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2025\/10\/chemists-discover-antibiotic-for-drug-resistant-bacteria-hiding-in-plain-sight","title":{"rendered":"Chemists discover antibiotic for drug-resistant bacteria \u2018hiding in plain sight\u2019"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/chemists-discover-antibiotic-for-drug-resistant-bacteria-hiding-in-plain-sight3.jpg\"><\/a><\/p>\n<p>Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant bacterial pathogens, including MRSA and VRE<\/p>\n<p>Antimicrobial resistance (AMR) is one of the world\u2019s most urgent health challenges, with the WHO\u2019s <a href=\"https:\/\/www.who.int\/news\/item\/02-10-2025-who-releases-new-reports-on-new-tests-and-treatments-in-development-for-bacterial-infections\" target=\"_blank\">new report<\/a> showing there are \u2018too few antibacterials in the pipeline. Most of the \u2018low-hanging fruit\u2019 has already been found, and the limited commercial incentives deter investment in antibiotic discovery.<\/p>\n<p>In a study published in the <a href=\"https:\/\/pubs.acs.org\/10.1021\/jacs.5c12501\" target=\"_blank\"><i>Journal of the American Chemical Society<\/i><\/a>, researchers from the Monash Warwick Alliance Combating Emerging Superbug Threats Initiative have discovered a promising new antibiotic\u2014pre-methylenomycin C lactone.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chemists from the University of Warwick and Monash University have discovered a promising new antibiotic that shows activity against drug-resistant bacterial pathogens, including MRSA and VRE Antimicrobial resistance (AMR) is one of the world\u2019s most urgent health challenges, with the WHO\u2019s new report showing there are \u2018too few antibacterials in the pipeline. Most of the [\u2026]<\/p>\n","protected":false},"author":427,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,19,1495],"tags":[],"class_list":["post-224143","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-chemistry","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/224143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/427"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=224143"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/224143\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=224143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=224143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=224143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}